NextPlat (NASDAQ:NXPL) Posts Earnings Results

NextPlat (NASDAQ:NXPL) announced its quarterly earnings data on Wednesday. The company reported ($0.08) earnings per share for the quarter, FiscalAI reports. NextPlat had a negative net margin of 17.64% and a negative return on equity of 39.24%. The company had revenue of $13.75 million during the quarter.

NextPlat Trading Down 8.4%

Shares of NASDAQ NXPL traded down $0.06 during trading on Thursday, reaching $0.70. The stock had a trading volume of 115,731 shares, compared to its average volume of 350,111. NextPlat has a fifty-two week low of $0.43 and a fifty-two week high of $2.30. The business’s 50-day moving average price is $0.80 and its 200-day moving average price is $0.73. The company has a debt-to-equity ratio of 0.05, a quick ratio of 3.49 and a current ratio of 4.33. The company has a market cap of $18.04 million, a P/E ratio of -1.58 and a beta of 1.11.

Institutional Investors Weigh In On NextPlat

An institutional investor recently bought a new position in NextPlat stock. Simplicity Wealth LLC bought a new position in NextPlat Corp. (NASDAQ:NXPL) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 600,000 shares of the company’s stock, valued at approximately $497,000. Simplicity Wealth LLC owned 2.31% of NextPlat as of its most recent filing with the Securities and Exchange Commission. Institutional investors and hedge funds own 1.30% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of NextPlat in a research note on Tuesday. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, NextPlat currently has an average rating of “Sell”.

About NextPlat

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.